A simple injection that can help regrow damaged tissue has long been the dream of physicians and patients alike. A new study from researchers at UBC Okanagan takes a big step towards making that dream a reality with a device that makes encapsulating cells much faster, cheaper and more effective.
“The idea of injecting different kinds of tissue cells is not a new one,” says Keekyoung Kim, assistant professor of engineering at UBC Okanagan and study co-author. “It’s an enticing concept because by introducing cells into damaged tissue, we can supercharge the body’s own processes to regrow and repair an injury.”
Kim says everything from broken bones to torn ligaments could benefit from this kind of approach and suggests even whole organs could be repaired as the technology improves.
The problem, he says, is that cells on their own are delicate and tend not to survive when injected directly into the body.
“It turns out that to ensure cell survival, they need to be encased in a coating that protects them from physical damage and from the body’s own immune system,” says Mohamed Gamal, doctoral student in biomedical engineering and study lead author. “But it has been extremely difficult to do that kind of cell encapsulation, which has until now been done in a very costly, time consuming and wasteful process.”
Kim and Gamal have solved that problem by developing an automated encapsulation device that encases many cells in a microgel using a specialized blue laser and purifies them to produce a clean useable sample in just a few minutes. The advantage of their system is that over 85 per cent of the cells survive and the process can be easily scaled up.
“Research in this area has been hampered by the cost and lack of availability of mass-produced cell encapsulated microgels,” says Kim. “We’ve solved that problem and our system could provide thousands or even tens of thousands of cell-encapsulated microgels rapidly, supercharging this field of bioengineering.”
In addition to developing a system that’s quick and efficient, Gamal says the equipment is made up of readily available and inexpensive components.
“Any lab doing this kind of work could set up a similar system anywhere from a few hundred to a couple of thousand dollars, which is pretty affordable for lab equipment,” says Gamal.
The team is already looking at the next step, which will be to embed different kinds of stem cells—cells that haven’t yet differentiated into specific tissue types—into the microgels alongside specialized proteins or hormones called growth factors. The idea would be to help the stem cells transform into the appropriate tissue type once they’re injected.
“I’m really excited to see where this technology goes next and what our encapsulated stem cells are capable of.”
The Latest on: Injectable tissues
via Google News
The Latest on: Injectable tissues
- RadioMedix & Curium Announce Permanent HCPCS Code for DetectnetTM (copper Cu 64 dotatate injection)on January 25, 2021 at 11:44 pm
St. Louis, MO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that the Centers for Medicare & Medicaid Services (CMS) has granted Detectnet a perma ...
- Immunicum AB (publ) Receives FDA Orphan Drug Designation for Ilixadencel as a Treatment of Soft Tissue Sarcoma (STS)on January 25, 2021 at 11:10 pm
Immunicum AB (publ; IMMU.ST) announced today that it has received Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA) for the Company’s lead candidate, ilixadencel, a ...
- EUSA Pharma and BeiGene Announce Acceptance of a Biologics License Application for SYLVANT® (Siltuximab for Injection) in Chinaon January 25, 2021 at 4:00 am
EUSA Pharma Limited and BeiGene, Ltd. today announced that the Biologics License Application for SYLVANT ® was accepted by the China National Medical Products Administration and granted priority ...
- My Body Was Failing. I Started to Prepare for Death.on January 24, 2021 at 7:01 am
Afflicted with Crohn’s disease, the author lay in a hospital bed while waiting for help that seemed further away every day.
- In A First, FDA Approves Monthly Injectable Drug For HIV Patientson January 22, 2021 at 6:41 am
It’s a huge change in quality of life, health experts say, because patients won’t have to take multiple pills several times a day, timed around meals.
- Expanded PET imaging time window adds flexibility for neuroendocrine tumor patientson January 21, 2021 at 9:46 am
DOTATATE positron emission tomography/computed tomography (PET/CT) for patients with neuroendocrine neoplasms can be expanded from one hour to three hours post-injection, according to new research ...
- Provectus Biopharmaceuticals Announces Release of Preprint Manuscript Describing Preclinical ...on January 20, 2021 at 4:18 am
(GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that H. Lee Moffitt Cancer Center (Moffitt) has released a manuscript preprint describing how investigational autolytic cancer immunotherapy ...
- Killer Corey Johnson executed days after Covid delayed lethal injectionon January 14, 2021 at 8:50 pm
Convicted killer Corey Johnson is one of the final two federal executions scheduled before Donald Trump leaves office, with fellow inmate Dustin Higgs due to die on Friday ...
- Chemotherapy with light; only one injection requiredon January 13, 2021 at 9:04 pm
Researchers in South Korea have developed a phototherapy technology that can significantly increase efficiency while reducing the pain of chemotherapy and minimizing side effects after treatment. The ...
- Injection Pen Market to Top US$ 6 Bn in 2030; Arrival of COVID-19 Vaccines Projected to Surge Demandon January 13, 2021 at 4:01 am
Amid rising demand for better accuracy in administering required medications to patients the injection pen market is finding itself impressive growth opportunities A new study by Fact MR projects the ...
via Bing News